| Name | Title | Contact Details |
|---|
Integra Partners is a benefits management company that specializes in DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) network management. Founded in 2005 and based in New York City, with an additional location in Michigan, it operates as a subsidiary of Point32Health. The company connects over 4,000 DMEPOS provider locations with more than 50 health plans, serving over 20 million lives across various sectors, including Commercial, Medicare, and Medicaid. Integra Partners offers a range of services, including DMEPOS network management, cost optimization, provider enablement, and compliance coordination. Their modular solutions provide customizable tools for health plans, while technology integration enhances coordination between providers and payers. The company focuses on improving member satisfaction and operational efficiency for healthcare providers, ensuring access to quality in-home healthcare equipment for patients. With a commitment to transparency and adaptability, Integra Partners aims to enhance the quality of life in communities through integrated healthcare solutions.
Total Graphic Solutions is a Smyrna, GA-based company in the Business Services sector.
CareerShop is a Winter Garden, FL-based company in the Business Services sector.
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)
Power of ONE Discovery is a London, ON-based company in the Business Services sector.